Last updated: December 20, 2024
Sponsor: Emory University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Hiv
Pelvic Cancer
Cervical Cancer
Treatment
GeneXpert HPV test
The Mother Mentor program
Clinical Study ID
NCT06751030
STUDY00004817
U01CA275113
Ages 25-50 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients must be able to perform vaginal self-collection as well as give informedconsent
Exclusion
Exclusion Criteria:
Male gender
Age <25 or >50
Unknown or negative HIV status
Pregnancy
Hysterectomy
Inability to give informed consent Inability/refusal to perform vaginalself-collection
Study Design
Total Participants: 1500
Treatment Group(s): 2
Primary Treatment: GeneXpert HPV test
Phase:
Study Start date:
January 01, 2025
Estimated Completion Date:
June 30, 2026
Study Description
Connect with a study center
APIN Health Initiatives
Abuja,
NigeriaActive - Recruiting
University of Ibadan
Ibadan,
NigeriaActive - Recruiting
Nigeria Institute of Medical Research (NIMR
Lagos,
NigeriaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.